BioVie Inc.
BIVI
$1.97
-$0.10-4.83%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -10.41% | 35.64% | -23.52% | 10.43% | -11.11% |
| Depreciation & Amortization | -89.01% | 0.00% | 0.00% | 0.00% | 0.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 56.14% | 80.22% | -14.13% | 28.20% | -23.53% |
| Operating Income | -56.14% | -80.22% | 14.13% | -28.20% | 23.53% |
| Income Before Tax | -61.80% | -89.01% | 14.66% | -22.53% | 29.38% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -61.80% | -89.01% | 14.66% | -22.53% | 29.38% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -61.80% | -89.01% | 14.66% | -22.53% | 29.38% |
| EBIT | -56.14% | -80.22% | 14.13% | -28.20% | 23.53% |
| EBITDA | -58.45% | -81.79% | 14.24% | -28.60% | 23.82% |
| EPS Basic | 62.06% | 53.63% | 83.17% | 85.94% | 76.77% |
| Normalized Basic EPS | 62.06% | 53.64% | 83.07% | 84.96% | 76.77% |
| EPS Diluted | 62.06% | 53.64% | 83.09% | 85.94% | 76.77% |
| Normalized Diluted EPS | 62.06% | 53.64% | 83.07% | 84.96% | 76.77% |
| Average Basic Shares Outstanding | 326.43% | 307.62% | 403.96% | 715.00% | 204.01% |
| Average Diluted Shares Outstanding | 326.43% | 307.62% | 403.96% | 715.00% | 204.01% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |